The invention relates to amidic oxotetrahydro-2H-furo[3.2-b]pyrrol-4(5H)-yl) derivatives as dual CatS/K inhibitors, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
[EN] 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES II<br/>[FR] DÉRIVÉS II DU 3-OXO-TÉTRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YLE
申请人:GRUENENTHAL GMBH
公开号:WO2015161924A1
公开(公告)日:2015-10-29
The invention relates to amidic oxotetrahydro-2H-furo[3.2-b]pyrrol-4(5H)-yl) derivatives as dual CatS/K inhibitors exhibiting a pronounced CatK-inhibition, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
申请人:Borchardt Allen
公开号:US20050176701A1
公开(公告)日:2005-08-11
The invention relates to compounds of the formula 1
and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R
1
and R
2
, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.
Picoline derivative useful as gastric acid secretion inhibitors
申请人:Byk Gulden Lomberg Chemische Fabrik GmbH
公开号:US04686230A1
公开(公告)日:1987-08-11
Picoline derivatives of the formula I ##STR1## wherein the substituents have the meanings given in the description, and their salts are new compounds having a pronounced protective action on the stomach.